Lv1
75 积分 2022-03-07 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
30天前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
30天前
已完结
A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab
1个月前
已关闭
Bioinspired Tumor Calcification‐Guided Early Diagnosis and Eradication of Hepatocellular Carcinoma
3个月前
已完结
Nanoparticles in NAFLD therapeutics
3个月前
已完结
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
4个月前
已完结
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous hepatocellular carcinoma
4个月前
已完结
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
5个月前
已完结
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous hepatocellular carcinoma
6个月前
已完结
Killing tumor-associated bacteria with a liposomal antibiotic generates microbial neoantigens that induce anti-tumor immune responses
7个月前
已关闭
皖公网安备34019202002308
